Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findeisen, P.
Right arrow Articles by von Knebel Doeberitz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Findeisen, P.
Right arrow Articles by von Knebel Doeberitz, M.
[Cancer Research 65, 8072-8078, September 15, 2005]
© 2005 American Association for Cancer Research


Priority Reports

T25 Repeat in the 3' Untranslated Region of the CASP2 Gene: A Sensitive and Specific Marker for Microsatellite Instability in Colorectal Cancer

Peter Findeisen1,2, Matthias Kloor1, Sabine Merx1,2, Christian Sutter1,3, Stefan M. Woerner1, Nicole Dostmann1, Axel Benner4, Bolormaa Dondog5, Michael Pawlita5, Wolfgang Dippold6, Rudolf Wagner7, Johannes Gebert1 and Magnus von Knebel Doeberitz1

1 Department of Pathology, Institute of Molecular Pathology; 2 Institute of Clinical Chemistry, Medical Faculty Mannheim; 3 Department of Human Genetics, Institute of Human Genetics, University of Heidelberg; 4 Central Unit Biostatistics, 5 Research Program Infection and Cancer, German Cancer Research Center, Heidelberg, Germany; 6 St. Vincenz und Elisabeth-Hospital, Mainz, Germany; and 7 Institute of Pathology, Westpfalz Klinikum, Kaiserslautern, Germany

Requests for reprints: Magnus von Knebel Doeberitz, Department of Pathology, Institute of Molecular Pathology, University of Heidelberg, Im Neuenheimer Feld 220, D-69120 Heidelberg, Germany. Phone: 49-6221-56-2876; Fax: 49-6221-56-5981; E-mail: knebel{at}med.uni-heidelberg.de and mvkd{at}aol.com.

DNA mismatch repair deficiency is observed in about 10% to 15% of all colorectal carcinomas and in up to 90% of hereditary nonpolyposis colorectal cancer (HNPCC) patients. Tumors with mismatch repair defects acquire mutations in short repetitive DNA sequences, a phenomenon termed high-level microsatellite instability (MSI-H). The diagnosis of MSI-H in colon cancer is of increasing relevance, because MSI-H is an independent prognostic factor in colorectal cancer, seems to influence the efficacy of adjuvant chemotherapy, and is the most important molecular screening tool to identify HNPCC patients. To make MSI typing feasible for the routine pathology laboratory, highly reproducible and cost effective laboratory tests are required. Here, we describe a novel T25 mononucleotide marker in the 3'untranslated region of the CASP2 gene (CAT25) that displayed a quasimonomorphic repeat pattern in normal tissue of 200 unrelated individuals of Caucasian origin. In addition, CAT25 was monomorphic also in all tested donors of African and Asian origin (n = 102 and n = 79, respectively) and thus differs from the most commonly used markers BAT25 and BAT26. Without the analysis of corresponding normal tissue, CAT25 correctly detected 56 of 57 colorectal cancer specimens classified as MSI-H by using the standard National Cancer Institute/International Collaborative Group-HNPCC marker panel. Combined with the standard markers BAT25 and BAT26 in a multiplex PCR, all MSI-H colorectal cancer samples were typed correctly. No false-positive results were obtained in 60 non-MSI-H control colorectal cancer specimens. These data suggest that CAT25 should be included into novel marker panels for microsatellite testing thus allowing for a significant reduction of the complexity and costs of MSI typing. Moreover, CAT25 represents a highly promising marker for early detection of colorectal cancer in HNPCC germ line mutation carriers.




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
F. Bianchi, E. Galizia, R. Catalani, L. Belvederesi, C. Ferretti, F. Corradini, and R. Cellerino
CAT25 Is a Mononucleotide Marker to Identify HNPCC Patients
J. Mol. Diagn., May 1, 2009; 11(3): 248 - 252.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Roeckel, S. M. Woerner, M. Kloor, Y.-P. Yuan, G. Patsos, R. Gromes, J. Kopitz, and J. Gebert
High Frequency of LMAN1 Abnormalities in Colorectal Tumors with Microsatellite Instability
Cancer Res., January 1, 2009; 69(1): 292 - 299.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Imai and H. Yamamoto
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Carcinogenesis, April 1, 2008; 29(4): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
V. Deschoolmeester, M. Baay, W. Wuyts, E. Van Marck, N. Van Damme, P. Vermeulen, K. Lukaszuk, F. Lardon, and J. B. Vermorken
Detection of Microsatellite Instability in Colorectal Cancer Using an Alternative Multiplex Assay of Quasi-Monomorphic Mononucleotide Markers
J. Mol. Diagn., March 1, 2008; 10(2): 154 - 159.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.